Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as Add-on to Levodopa in Parkinson's Disease
NCT07055958Phase 3Active, not recruiting
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Dec 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing Metformin + Levodopa with Placebo + Levodopa (2 arms). Primary endpoint: Motor Aspects of Experiences of Daily Living (MDS-UPDRS Part II) at 8 weeks. Started Dec 2024; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07055958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07055958.